
3.52 Delayed Data As of Sep 22 | ![]() Today’s Change | 2.24 Today|||52-Week Range 4.65 | -9.28% Year-to-Date |
The 4 analysts offering 12-month price forecasts for ADMA Biologics Inc have a median target of 6.00, with a high estimate of 7.00 and a low estimate of 5.00. The median estimate represents a +70.45% increase from the last price of 3.52.
The current consensus among 4 polled investment analysts is to Buy stock in ADMA Biologics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.